Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNF | P01375 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | BLM | P54132 | 2/20 | 0.62 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | MPO | P05164 | 1/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.62 |
| ▸ | HTR2A | P28223 | 2/20 | 0.55 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | HTR1A | P08908 | 1/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.51 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30495964 | 1.00 | TNF (0.64) | TNFKMT2AKDM4ELMNAMAPT | |
| SCHEMBL18028962 | 1.00 | TNF (0.64) | TNFKMT2AKDM4ELMNAMAPT | |
| SCHEMBL3467251 | 1.00 | TNF (0.64) | TNFKMT2AKDM4ELMNAMAPT | |
| SCHEMBL838121 | 1.00 | TNF (0.64) | TNFKMT2AKDM4ELMNAMAPT | |
| SCHEMBL19846988 | 0.88 | HTR2A (0.54) | TNFKMT2AKDM4ELMNAMAPT | |
| SCHEMBL1460647 | 0.86 | MAPT (0.69) | TNFKMT2AKDM4ELMNAMAPT | |
| SCHEMBL18029110 | 0.86 | MAPT (0.69) | TNFKMT2AKDM4ELMNAMAPT | |
| SCHEMBL1460650 | 0.86 | MAPT (0.69) | TNFKMT2AKDM4ELMNAMAPT | |
| SCHEMBL24328355 | 0.84 | SMN1; SMN2 (0.61) | TNFKMT2AKDM4ELMNAMAPT | |
| SCHEMBL20816074 | 0.84 | MAPT (0.63) | TNFKMT2AKDM4ELMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240260865-A1 | METHOD OF PRODUCING THIN ENZYME-BASED SENSING LAYERS ON PLANAR SENSORS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2024-08-08 | — | — | US | claimed |
| CN-118207197-A | Immobilization of thermophilic archaea tryptophan synthase on magnetic bead-T4 phage capsid composite carrier | 江苏海洋大学 | 2024-06-18 | — | — | CN | claimed |
| US-11903708-B2 | Switchable low voltage electrochemical sensing for interfering species rejection | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2024-02-20 | — | — | US | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| US-11690544-B2 | Method of producing thin enzyme-based sensing layers on planar sensors | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2023-07-04 | — | — | US | claimed |
| CN-111118048-B | Use of chimeric phenylalanyl-tRNA synthetases/tRNAs | 浙江大学 | 2022-06-10 | — | — | CN | claimed |
| US-20200247858-A1 | AGENTS MODULATING BETA-CATENIN FUNCTIONS AND METHODS THEREOF | FOG PHARMACEUTICALS, INC. (US) | 2020-08-06 | — | — | US | claimed |
| EP-3678683-A2 | AGENTS MODULATING BETA-CATENIN FUNCTIONS AND METHODS THEREOF | Fog Pharmaceuticals, Inc. (US) | 2020-07-15 | — | — | EP | claimed |
| CN-111372942-A | β -catenin function modulating agents and methods thereof | 弗格制药有限公司 | 2020-07-03 | — | — | CN | claimed |
| WO-2019051327-A2 | AGENTS MODULATING BETA-CATENIN FUNCTIONS AND METHODS THEREOF | FOG PHARMACEUTICALS, INC. (US) | 2019-03-14 | — | — | WO | claimed |
| EP-3335720-A1 | C-DI-GMP BINDING PEPTIDES | Universität Basel (CH) | 2018-06-20 | — | — | EP | claimed |
| US-6117670-A | NUCLEIC ACID SEQUENCE THAT CODES AN ENZYMATIC PROTEIN WHICH PREVENTS INFECTION AND PROPAGATION OF PHYTOPATHOGENS IN PLANTS; FOR BIOLOGICAL PEST CONTROL; BACTERICIDES | NOVARTIS FINANCE CORPORATION (US) | 2000-09-12 | — | — | US | claimed |
| US-5817502-A | GENETIC ENGINEERING; GENE EXPRESSION OF A POLYPEPTIDE | NOVARTIS FINANCE CORPORATION (US) | 1998-10-06 | — | — | US | claimed |
| US-20260071243-A1 | BIOLOGICAL PRODUCTION OF TRYPTOPHAN-DERIVED PRODUCTS | UNIV TEXAS (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260022515-A2 | PROCESS FOR DYEING TEXTILES | SANKO TEKSTIL ISLETMELERI SAN VE TIC AS (TR) | 2026-01-22 | — | — | US | disclosed |
| US-20250354108-A1 | METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS | UNIV DANMARKS TEKNISKE (DK) | 2025-11-20 | — | — | US | disclosed |
| EP-1132480-A1 | Method for producing halo-L-tryptophan | Ajinomoto Co., Inc. (JP) | 2001-09-12 | — | — | EP | disclosed |
| WO-2001044447-A1 | COMPOSITIONS AND METHODS FOR HALOGENATION REACTIONS | SYNGENTA PARTICIPATIONS AG (CH) | 2001-06-21 | — | — | WO | disclosed |
| US-6117670-A | NUCLEIC ACID SEQUENCE THAT CODES AN ENZYMATIC PROTEIN WHICH PREVENTS INFECTION AND PROPAGATION OF PHYTOPATHOGENS IN PLANTS; FOR BIOLOGICAL PEST CONTROL; BACTERICIDES | NOVARTIS FINANCE CORPORATION (US) | 2000-09-12 | — | — | US | disclosed |
| US-5817502-A | GENETIC ENGINEERING; GENE EXPRESSION OF A POLYPEPTIDE | NOVARTIS FINANCE CORPORATION (US) | 1998-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022515-A2 | PROCESS FOR DYEING TEXTILES | TDO2, TPH2, IDO2 | TNF 2010/4885KMT2A 693/4885KDM4E 522/4885 |
| US-20200247858-A1 | AGENTS MODULATING BETA-CATENIN FUNCTIONS AND METHODS THEREOF | CTNNB1, CTNNBL1, CTNNA1 | TNF 2185/4885KMT2A 3036/4885KDM4E 1902/4885 |
| US-20260071243-A1 | BIOLOGICAL PRODUCTION OF TRYPTOPHAN-DERIVED PRODUCTS | TPH1, TPH2, SLC6A4 | TNF 2121/4885KMT2A 1283/4885KDM4E 3485/4885 |
| US-20250354108-A1 | METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS | INMT, KARS1, MIA3 | TNF 4064/4885KMT2A 445/4885KDM4E 2243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.